The Jackson Laboratory, an independent, nonprofit biomedical research institution, on October 4 announced the appointment of Lon Cardon, Ph.D., FMedSci, a pioneer in human genetics and drug discovery, as its next President and Chief Executive Officer. Effective November 29, Cardon will succeed current President and CEO Edison Liu, M.D.
In his new role, Cardon will develop and drive a clear, integrated strategy for the Laboratory’s continued long-term success, leveraging the unique and powerful interplay of JAX’s deep expertise in mammalian genetics and human genomics combined with the latest advances in digital technologies such as artificial intelligence, machine learning, and new computation platforms as well as its research, educational, and business strengths.
“For many years there has been immense promise to translate human genetics and genomics discoveries into new diagnostics, prognostics and treatments for both common and rare diseases,” said Cardon. “Many of the foundational pieces are finally coming into place. The next step is to put them together to begin to realize this promise.”